Form 8-K - Current report:
SEC Accession No. 0001654954-19-002574
Filing Date
2019-03-12
Accepted
2019-03-12 08:38:08
Documents
3
Period of Report
2019-03-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sbfm_8k.htm 8-K 25683
2 PRESS RELEASE sbfm_ex998.htm EX-99.8 8842
3 IMAGE sunshinebio.jpg GRAPHIC 5888
  Complete submission text file 0001654954-19-002574.txt   44196
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

EIN.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52898 | Film No.: 19674025
SIC: 8731 Services-Commercial Physical & Biological Research